Cidara Therapeutics (CDTX) Short Interest Ratio & Short Volume $19.30 +4.18 (+27.65%) (As of 09:04 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cidara Therapeutics Short Interest DataCidara Therapeutics (CDTX) has a short interest of 64,600 shares, representing 1.05% of the float (the number of shares available for trading by the public). This marks a -3.58% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 38,353 shares to cover all short positions.Current Short Interest64,600 sharesPrevious Short Interest67,000 sharesChange Vs. Previous Month-3.58%Dollar Volume Sold Short$839,800.00Short Interest Ratio3.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares7,050,000 sharesFloat Size6,150,000 sharesShort Percent of Float1.05%Today's Trading Volume47,972 sharesAverage Trading Volume38,353 sharesToday's Volume Vs. Average125% Short Selling Cidara Therapeutics? Sign up to receive the latest short interest report for Cidara Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCDTX Short Interest Over TimeCDTX Days to Cover Over TimeCDTX Percentage of Float Shorted Over Time Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Cidara Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202464,600 shares $839,800.00 -3.6%1.1%3.2 $13.00 10/15/202467,000 shares $681,390.00 -20.1%1.1%3.4 $10.17 9/30/202483,800 shares $900,850.00 +28.7%1.4%4.1 $10.75 9/15/202465,100 shares $777,294.00 -14.6%1.1%2.4 $11.94 8/31/202476,200 shares $906,018.00 -23.2%1.2%2.5 $11.89 8/15/202499,200 shares $1.25 million -1.5%1.6%2.7 $12.64 Get the Latest News and Ratings for CDTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cidara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024100,700 shares $1.31 million -11.7%1.5%2.6 $13.00 7/15/2024114,000 shares $1.43 million +2.2%2.6%1.7 $12.50 6/30/2024111,500 shares $1.33 million -1.9%2.6%1.6 $11.94 6/15/2024113,600 shares $1.53 million +5.8%2.6%1.5 $13.44 5/31/2024107,400 shares $1.36 million +53.2%2.5%1.5 $12.69 5/15/202470,100 shares $890,971.00 -16.3%1.7%1 $12.71 4/30/202483,700 shares $1.00 million +920.7%2.0%1.4 $11.98 4/15/20248,200 shares $135,250.80 -95.8%N/A0.2 $16.49 3/31/2024195,400 shares $179,768.00 +8.9%N/A0.3 $0.92 3/15/2024179,500 shares $122,939.55 -18.9%N/A0.3 $0.68 2/29/2024221,400 shares $156,640.50 -52.2%N/A0.3 $0.71 2/15/2024463,300 shares $320,742.59 -22.1%N/A0.7 $0.69 1/31/2024594,500 shares $381,193.40 -4.7%N/A0.9 $0.64 1/15/2024623,800 shares $477,830.80 -38.8%N/A1.1 $0.77 12/31/20231,020,000 shares $809,880.00 +44.3%N/A1.8 $0.79 12/15/2023707,100 shares $505,930.05 -23.6%N/A1.3 $0.72 11/30/2023925,600 shares $656,620.64 -24.8%N/A2.7 $0.71 11/15/20231,230,000 shares $953,250.00 -0.8%N/A2.8 $0.78 10/31/20231,240,000 shares $951,080.00 -6.1%N/A2.7 $0.77 10/15/20231,320,000 shares $1.21 million -12.0%N/A2.6 $0.92 9/30/20231,500,000 shares $1.41 million -3.9%N/A2.6 $0.94 9/15/20231,560,000 shares $1.67 million +31.1%N/A2.6 $1.07 8/31/20231,190,000 shares $933,079.00 -16.2%N/A1.8 $0.78 8/15/20231,420,000 shares $1.29 million -8.4%N/A2.3 $0.91 7/31/20231,550,000 shares $1.54 million -4.9%N/A1.8 $1.00 7/15/20231,630,000 shares $1.79 million -6.9%N/A1.7 $1.10 6/30/20231,750,000 shares $1.98 million +17.5%N/A1.6 $1.13 6/15/20231,490,000 shares $1.70 million -22.0%N/A0.8 $1.14 5/31/20231,910,000 shares $2.54 million -14.0%N/A0.7 $1.33 5/15/20232,220,000 shares $3.02 million -7.9%N/A0.7 $1.36 4/30/20232,410,000 shares $2.46 million -21.8%N/A0.8 $1.02 4/15/20233,080,000 shares $3.33 million -13.2%N/A0.9 $1.08 3/31/20233,550,000 shares $4.51 million +63.6%N/A1 $1.27 3/15/20232,170,000 shares $3.65 million -30.0%N/A0.7 $1.68Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 2/28/20233,100,000 shares $4.68 million +56.6%N/A1.6 $1.51 2/15/20231,980,000 shares $3.15 million +13.1%N/A1.4 $1.59 1/31/20231,750,000 shares $2.15 million +141.3%N/A1.4 $1.23 1/15/2023725,200 shares $957,264.00 +27.9%N/A1.2 $1.32 12/30/2022567,100 shares $428,897.73 -7.1%N/A1.8 $0.76 12/15/2022610,200 shares $305,038.98 +12.8%N/A2.2 $0.50 11/30/2022540,900 shares $346,230.09 -25.3%N/A2.2 $0.64 11/15/2022724,300 shares $452,542.64 +45.6%N/A3 $0.62 10/31/2022497,400 shares $305,901.00 +22.7%N/A1.9 $0.62 10/15/2022405,300 shares $226,886.94 -11.2%N/A0.9 $0.56 9/30/2022456,500 shares $286,682.00 -23.2%N/A1 $0.63 9/15/2022594,400 shares $428,740.72 -0.8%N/A1.2 $0.72 8/31/2022599,300 shares $407,524.00 +38.8%N/A1.2 $0.68 8/15/2022431,800 shares $284,988.00 -49.4%N/A0.8 $0.66 7/31/2022853,500 shares $669,997.50 +58.8%N/A1.6 $0.79 7/15/2022537,500 shares $379,743.75 +16.1%N/A1.6 $0.71 6/30/2022463,100 shares $226,270.66 -16.0%N/A1.5 $0.49 6/15/2022551,100 shares $286,572.00 -13.0%N/A1.8 $0.52 5/31/2022633,100 shares $291,226.00 +18.9%N/A2.1 $0.46 5/15/2022532,400 shares $227,867.20 -17.4%N/A2 $0.43 4/30/2022644,300 shares $449,012.67 +16.9%N/A2.8 $0.70 4/15/2022551,400 shares $453,085.38 +7.3%N/A2.1 $0.82 3/31/2022513,900 shares $427,924.53 +2.5%N/A1.7 $0.83 3/15/2022501,500 shares $350,548.50 -6.4%N/A1.3 $0.70 2/28/2022535,700 shares $374,990.00 -9.7%N/A0.8 $0.70 2/15/2022593,300 shares $499,677.26 -13.7%N/A0.8 $0.84 1/31/2022687,500 shares $620,743.75 +25.4%N/A0.8 $0.90 1/15/2022548,100 shares $528,916.50 -8.6%N/A0.6 $0.97 12/31/2021599,600 shares $761,492.00 +18.8%N/A0.7 $1.27 12/15/2021504,700 shares $615,734.00 -18.6%N/A0.6 $1.22 11/30/2021619,900 shares $923,651.00 +33.2%N/A1.1 $1.49 11/15/2021465,500 shares $740,145.00 -13.0%N/A0.9 $1.59 10/29/2021535,200 shares $845,616.00 -7.9%1.2%1.2 $1.58 10/15/2021581,200 shares $976,416.00 -14.3%1.3%1.4 $1.68 9/30/2021678,300 shares $1.52 million +4.0%2.0%1.8 $2.24 9/15/2021652,400 shares $1.36 million -6.1%1.9%1.6 $2.09 8/31/2021694,500 shares $1.60 million -8.9%2.0%1.7 $2.30 8/13/2021762,100 shares $1.28 million +7.4%2.2%2 $1.68 7/30/2021709,500 shares $1.08 million -13.2%2.1%1.8 $1.52 7/15/2021817,300 shares $1.36 million -14.4%2.4%1.9 $1.67 6/30/2021954,500 shares $1.93 million -40.7%2.8%2.1 $2.02 6/15/20211,610,000 shares $3.38 million -1.8%4.8%3 $2.10 5/28/20211,640,000 shares $3.31 million -4.1%4.9%3 $2.02 5/14/20211,710,000 shares $3.45 million -10.9%N/A2.5 $2.02 4/30/20211,920,000 shares $4.40 million +6.1%N/A1.9 $2.29 4/15/20211,810,000 shares $3.91 million +11.7%N/A1.8 $2.16 3/31/20211,620,000 shares $3.68 million +5.9%N/A1.6 $2.27 3/15/20211,530,000 shares $4.07 million -4.4%N/A1.7 $2.66 2/26/20211,600,000 shares $3.89 million +0.6%N/A1.8 $2.43 2/12/20211,590,000 shares $3.86 million +12.0%N/A2 $2.43New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! 1/29/20211,420,000 shares $3.34 million -1.4%N/A2.7 $2.35 1/15/20211,440,000 shares $3.46 million -8.3%N/A3.4 $2.40 12/31/20201,570,000 shares $3.20 million -2.5%N/A4.2 $2.04 12/15/20201,610,000 shares $3.30 million +2.6%N/A5.4 $2.05 11/30/20201,570,000 shares $3.66 million +0.6%N/A6 $2.33 11/15/20201,560,000 shares $3.96 million -18.8%N/A6.4 $2.54 10/30/20201,920,000 shares $5.09 million -1.5%N/A9.5 $2.65 10/15/20201,950,000 shares $5.79 million -6.7%N/A11.3 $2.97 9/30/20202,090,000 shares $5.96 million No ChangeN/A11 $2.85 9/15/20202,090,000 shares $6.83 million -4.1%N/A7.3 $3.27 8/31/20202,180,000 shares $6.93 million -0.5%N/A8.2 $3.18 8/14/20202,190,000 shares $8.34 million -14.8%N/A8.4 $3.81 7/31/20202,570,000 shares $9.38 million +5.3%N/A8.9 $3.65 7/15/20202,440,000 shares $8.66 million +10.4%N/A8.3 $3.55 6/30/20202,210,000 shares $8.15 million +40.8%N/A7 $3.69 6/15/20201,570,000 shares $5.98 million No ChangeN/A6.9 $3.81 5/29/20201,570,000 shares $5.62 million +0.6%N/A6.2 $3.58 5/15/20201,560,000 shares $4.56 million -3.1%N/A5.3 $2.92 4/30/20201,610,000 shares $4.65 million -7.5%N/A5.6 $2.89 4/15/20201,740,000 shares $4.58 million -6.5%N/A5 $2.63 3/31/20201,860,000 shares $5.13 million -10.6%N/A5 $2.76 3/13/20202,079,600 shares $5.14 million +6.7%8.3%4.1 $2.47 2/28/20201,950,000 shares $4.31 million -11.8%7.8%5 $2.21 2/14/20202,210,000 shares $5.83 million +18.8%10.6%6.3 $2.64 1/31/20201,860,000 shares $5.39 million +51.2%9.0%5.5 $2.90 1/15/20201,230,000 shares $3.62 million -7.5%6.0%4 $2.94 12/31/20191,330,000 shares $4.62 million -15.8%6.3%6.2 $3.47 CDTX Short Interest - Frequently Asked Questions What is Cidara Therapeutics' current short interest? Short interest is the volume of Cidara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 64,600 shares of CDTX short. 1.05% of Cidara Therapeutics' shares are currently sold short. Learn More on Cidara Therapeutics' current short interest. What is a good short interest ratio for Cidara Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CDTX shares currently have a short interest ratio of 3.0. Learn More on Cidara Therapeutics's short interest ratio. What is a good short interest percentage for Cidara Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.05% of Cidara Therapeutics' floating shares are currently sold short. Is Cidara Therapeutics' short interest increasing or decreasing? Cidara Therapeutics saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 64,600 shares, a decline of 3.6% from the previous total of 67,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cidara Therapeutics' float size? Cidara Therapeutics currently has issued a total of 7,050,000 shares. Some of Cidara Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cidara Therapeutics currently has a public float of 6,150,000 shares. How does Cidara Therapeutics' short interest compare to its competitors? 1.05% of Cidara Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cidara Therapeutics: X4 Pharmaceuticals, Inc. (6.70%), SCYNEXIS, Inc. (2.28%), Alpha Teknova, Inc. (2.71%), Taysha Gene Therapies, Inc. (8.61%), Canopy Growth Co. (9.77%), Akebia Therapeutics, Inc. (6.80%), 4D Molecular Therapeutics, Inc. (17.69%), Alvotech (0.07%), Larimar Therapeutics, Inc. (4.26%), KalVista Pharmaceuticals, Inc. (15.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Cidara Therapeutics stock? Short selling CDTX is an investing strategy that aims to generate trading profit from Cidara Therapeutics as its price is falling. CDTX shares are trading down $0.51 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cidara Therapeutics? A short squeeze for Cidara Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CDTX, which in turn drives the price of the stock up even further. How often is Cidara Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDTX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies XFOR Short Interest SCYX Short Interest ATXS Short Interest CRVS Short Interest ORGO Short Interest PRTC Short Interest MREO Short Interest GLUE Short Interest PROK Short Interest RGNX Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CDTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cidara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cidara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDTX Stock Alerts